The Dose Adjustment For Normal Eating (DAFNE) Trial: improvements in HbAlc still apparent and quality of life benefits well maintained at 4-year follow-up
journal contribution
posted on 2007-01-01, 00:00authored byJ Speight, S Amiel, C Bradley, S Heller, P James, L Oliver, S Roberts, H Rogers, C Taylor, G Thompson
The Dose Adjustment For Normal Eating (DAFNE) Trial: improvements in HbAlc still apparent and quality of life benefits well maintained at 4-year follow-up